 | Up a level |
Dai, Xiangpeng; Gan, Wenjian; Li, Xiaoning; Wang, Shangqian; Zhang, Wei; Huang, Ling; Liu, Shengwu; Zhong, Qing; Guo, Jianping; Zhang, Jinfang; Chen, Ting; Shimizu, Kouhei; Beca, Francisco; Blattner, Mirjam; Vasudevan, Divya; Buckley, Dennis L; Qi, Jun; Buser, Lorenz; Liu, Pengda; Inuzuka, Hiroyuki; ... (2017). Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4. Nature medicine, 23(9), pp. 1063-1071. Nature Publishing Group 10.1038/nm.4378
Beer, Marc; Montani, Matteo; Gerhardt, Josefine; Wild, Peter J; Hany, Thomas F; Hermanns, Thomas; Müntener, Michael; Kristiansen, Glen (2012). Profiling gastrin-releasing peptide receptor in prostate tissues: clinical implications and molecular correlates. Prostate, 72(3), pp. 318-25. Hoboken, N.J.: Wiley-Blackwell 10.1002/pros.21434
Mortezavi, Ashkan; Hermanns, Thomas; Seifert, Hans-Helge; Baumgartner, Martin K; Provenzano, Maurizio; Sulser, Tullio; Burger, Maximilian; Montani, Matteo; Ikenberg, Kristian; Hofstädter, Ferdinand; Hartmann, Arndt; Jaggi, Rolf; Moch, Holger; Kristiansen, Glen; Wild, Peter J (2011). KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clinical cancer research, 17(5), pp. 1111-21. Philadelphia, Pa.: American Association for Cancer Research 10.1158/1078-0432.CCR-10-0081
